awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38065877-6E002238-B45D-412F-90CF-0C6F8A3752E3
Q38065877-6E002238-B45D-412F-90CF-0C6F8A3752E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38065877-6E002238-B45D-412F-90CF-0C6F8A3752E3
Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab).
P2860
Q38065877-6E002238-B45D-412F-90CF-0C6F8A3752E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38065877-6E002238-B45D-412F-90CF-0C6F8A3752E3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
48f769f73aec758952fecd424d72abfab9588866
P2860
The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment.